Demand for functional food and drink has shot up in APAC, particularly in China, where 80% of the population claims to want to make their diets more healthy. And four key health concerns are driving sales.
Supplement and functional food firms must appeal to consumers’ emotions if they want new products to sell well in Asia's more developed nations, according to Frost & Sullivan’s Asia-Pacific director Natasha Telles D’Costa.
Hong Kong, China, Vietnam, Malaysia and Indonesia are tipped to be among the fastest growing functional food and fortified product markets in APAC to 2021, while Japan is witnessing a wave of product innovation on the back of its new Food with Function...
Athletes in India must be better educated on the detrimental effects of doping and regulators must introduce stricter labelling rules for over-the-counter supplements, president of the All India Council of Sports Vijay Kumar Malhotra has said.
The ever-growing importance of e-commerce sales for supplements in APAC was underlined in our first state of the industry survey, with almost 70% of respondents believing the channel will ultimately become as important as brick-and-mortar retail.
Consumption of whey growth factor extract (WGFE) in addition to whey protein isolate offers few benefits to men who are not new to resistance exercise training, according to a study led by the University of South Australia.
The US-China Health Products Association (USCHPA) will be hosting the annual China International Sports Nutrition Industry Summit — with sponsors GNC and Glanbia Nutritionals — in Shanghai on 6 September this year.
The raft of new supplement and functional food regulations introduced in the past two years, or those imminently pending, have been broadly welcomed by the industry in APAC, according to the findings of our inaugural State of the Supplements, Health &...
The seventh edition of Vitafoods Asia, which will be held in Singapore for the first time, will see more than 250 exhibitors and 3,000 delegates at the Sands Expo and Convention Centre in Marina Bay Sands.
Health product manufacturer TSI Group has announced the approval of the first ever China Food and Drug Administration (CFDA) Manufacturing Licence for β-hydroxy β-methylbutyrate (HMB) production in China.